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HLA region. Outside the HLA region, suggestive evidence for 
linkage was obtained at the telomeric region of chromo-
some 10 (10q26.12-qter; p = 0.00366), and on chromosome 8 
(8q22.2-q24.21; p = 0.00491). Testing signals of association 
and linkage within bins showed no significant evidence for 
co-localization of results.  Conclusion: This meta-analysis al-
lowed us to pool the results from available genome-wide 
linkage studies and to identify novel regions potentially har-
boring predisposing genetic variation contributing to CD. 
This study also shows that linkage and association studies 
may identify different types of disease-predisposing vari-
ants.  Copyright © 2009 S. Karger AG, Basel 
 Introduction 
 Celiac disease (CD) is an inflammatory disorder of the 
small intestine with a complex etiology, triggered by di-
etary gluten. The disease prevalence is estimated to be up 
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 Abstract 
 Objective: A meta-analysis of genome-wide linkage studies 
allows us to summarize the extensive information available 
from family-based studies, as the field moves into genome-
wide association studies.  Methods: Here we apply the ge-
nome scan meta-analysis (GSMA) method, a rank-based, 
model-free approach, to combine results across eight inde-
pendent genome-wide linkages performed on celiac dis-
ease (CD), including 554 families with over 1,500 affected in-
dividuals. We also investigate the agreement between 
signals we identified from this meta-analysis of linkage stud-
ies and those identified from genome-wide association 
analysis using a hypergeometric distribution.  Results: Not 
surprisingly, the most significant result was obtained in the 
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to 1% in Western populations. In addition to the classical 
gastrointestinal form, a variety of other clinical manifes-
tations of the disease have been described, including 
atypical and asymptomatic forms  [1] . The most common 
extra-intestinal manifestation is dermatitis herpetifor-
mis (DH), a blistering skin condition, currently regarded 
as a variant of CD, affecting one-quarter of the patients 
with gluten intolerance. Asymptomatic forms are charac-
terized by the presence of histological changes, identified 
through screening programs on apparently healthy sub-
jects.
 The only genetic factor indisputably involved in CD is 
the human leukocyte antigen (HLA) locus, where a clear 
association has been found with HLA-DQ variants  [2] . 
However, the HLA association alone is insufficient to ex-
plain the hereditary nature of the disease  [3] , indicating 
that additional, non-HLA genes must also be involved in 
disease susceptibility.
 Several independent genome-wide scans in multiplex 
families have identified genomic regions that may harbor 
susceptibility genes for CD, but few studies have shown 
significant evidence for linkage outside the HLA region, 
and there is little convincing replication of linked regions 
across studies. This is typical of linkage studies for com-
plex diseases, and is likely due to the low power of studies 
to detect genes of relatively small effect and to the high 
degree of genetic heterogeneity among families. Promis-
ing loci include a region on 5q31-33 ( CELIAC2 ) which was 
identified in several linkage studies  [4–6] and in a meta-
analysis and a pooled genotype analysis of data from the 
European Genetics Cluster on Coeliac Disease  [7] . A lo-
cus on chromosome 19p13.1 ( CELIAC 4 ), which was iden-
tified in a Dutch linkage study  [8] , harbors a functional 
candidate gene implicated in intestinal barrier integrity 
( MYO9B , MIM: 602129) for which an intronic SNP shows 
significant association with CD  [9] .
 More recently, one genome-wide association (GWA) 
study has been published  [10] , with follow-up of top re-
gions confirming eight novel, non-HLA regions associ-
ated with CD  [11] . These studies, and other previous 
studies focusing on candidate genes, have identified evi-
dence of association with common variants, generally 
with only minor effect on disease risk.
 A meta-analysis of genome-wide linkage studies, to 
summarize the available information in these extensive 
family-based studies, is timely as the field moves into ge-
nome-wide association studies. We use the genome scan 
meta-analysis (GSMA) method  [12] to combine results 
across linkage studies, and identify regions which may 
harbor genetic determinants for CD. We also investigate 
the agreement between signals of genome-wide linkage 
and association analysis to test whether CD-associated 
SNPs are over-represented in linked regions.
 Material and Methods 
 GSMA 
 The genome scan meta-analysis (GSMA) method  [12] was 
used to combine linkage results from CD genome screens. The 
GSMA method is designed to deal with dissimilarity in study de-
sign, marker panels, analysis methods, and linkage statistics used 
in different genome scans. The GSMA uses only genome-wide 
linkage results, with no original genotype or family data required. 
To apply the GSMA method the genome needs to be fragmented 
into bins of approximately equal length. Using a bin width of 
 approximately    30    cM,    118   bins   provided   the   most   even   cov-
erage across autosomes based on the Marshfield linkage maps 
(http://research.marshfieldclinic.org/genetics/home/index.asp) 
 [13] , with chromosome 1 having 10 bins, and chromosomes 21 
and 22 having 2 bins each  [14] .
 For each scan, the maximum value of the linkage statistic ob-
tained in each bin was identified. The bins were then ranked, 
from the lowest (rank = 1) to the highest (rank = 118) value of the 
linkage statistic across the genome. Bin ranks were then summed 
across studies and the summed rank (SR) was compared to its 
probability distribution under the null hypothesis of no linkage 
(i.e. assuming ranks were randomly assigned to a bin). The sig-
nificance of the SR in each bin was assessed with the GSMA soft-
ware which obtains an empirical p value for the observed SR in 
each bin, using Monte Carlo simulations permuting the bin loca-
tion of the ranks within each study (http://www.kcl.ac.uk/schools/
medicine/depts/memoge/research/epidemiology/gsma/index.
html)  [15] . To control for multiple testing of bins, we used a Bon-
ferroni correction. For 30 cM width bins, a p value of 0.05/118 = 
0.00042 was required for genome-wide evidence of linkage, or a 
p value of 1/118 = 0.00847 for suggestive evidence of linkage over 
the autosomes, corresponding to the SR p values expected to arise 
by chance once in 20 GSMA studies, and once in a single GSMA 
study, respectively.
 Meta-analysis of CD was performed both unweighted (assum-
ing equal contribution from each study) and weighted by study 
size. The weighting factor for each study was defined as the square 
root of (# affecteds – # families), scaled to a mean of 1. Analyses 
under different weighting functions produced similar results, and 
are not reported. The primary statistical analysis used 30 cM bin 
widths; chromosomes showing suggestive evidence for linkage 
(under weighted or unweighted analysis) were analysed further 
using bins of 10 and 20 cM width in order to improve the localiza-
tion of linkage signals detected.
 CD Linkage Studies 
 In total, 13 published genome scans of CD families were iden-
tified through a review of the literature and through PubMed 
search. Only whole genome-wide linkage scan analyses were con-
sidered, with partial scans and follow-up studies in candidate re-
gions excluded. One study  [16] was an update of a previous study, 
with a larger family collection, and the earlier study was therefore 
omitted  [17] . We also excluded a study of a single four-generation 
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Dutch pedigree (17 affecteds) with disease transmission following 
a Mendelian pattern  [18] , and two studies performed in extended, 
consanguineous families from a Finnish genetic isolate  [19] and a 
Bedouin population in the Negev Desert  [20] . These studies were 
not included as the loci involved in these families may not play a 
major role in CD as a multifactorial disorder represented in the 
other studies. Finally, we also excluded a small, low-powered 
study for which only best peaks were available from the published 
paper  [21] .
 Authors of identified studies were contacted by e-mail and in-
vited to contribute linkage results required for the meta-analysis. 
All groups agreed to participate in the meta-analysis, providing 
multipoint non-parametric linkage statistics across the genome, 
with results of one study being extracted from published graphs 
 [22] .
 The eight independent CD studies analysed consisted of 554 
families and over 1,500 affected individuals ( table 1 ). All studies 
were of European ancestry and comprised sibships with at least 
two affected children or families with more distant affected rela-
tive pairs. X chromosome results were available for only four 
studies and were therefore not analysed.
 Five studies included only patients diagnosed with classic CD, 
while three studies  [5, 16, 22] also included patients with derma-
titis herpetiformis (DH). DH and CD share a common immuno-
genetic background but may be heterogeneous gluten-sensitive 
diseases, and we therefore performed a separate analysis of the 
five CD-only.
 Data Extraction 
 Linkage results obtained from investigators consisted of com-
puter files from analysis programs showing linkage statistics 
(NPL score, p value, etc.) at each marker genotyped or at specific 
genetic locations. For results with marker data  [4, 5, 23] , we first 
mapped markers to locations on the Marshfield linkage map and 
then determined the bin location of each marker using the previ-
ously defined bin boundaries. For results indexed by genetic loca-
tion  [6, 8, 16, 24] , we determined the locations of the first and last 
markers genotyped on each chromosome and then rescaled the 
genetic locations of the linkage statistics accordingly, before di-
viding the chromosome into the required number of bins. This 
correction overcomes the problem of bin shifting when the first 
or last marker genotyped on a chromosome is located several cM 
from the telomere, and ensures that bins from each study cover 
the same genetic region, regardless of data format. Data was ex-
tracted from genome-wide linkage graphs  [22] , using Engauge 
Digitizer (http://digitizer.sourceforge.net/) and chromosomes di-
vided into the required number of equal width bins  [14] .
 After markers and linkage statistic locations for each study 
had been localized onto the Marshfield map, we then identified 
the maximum linkage statistic per bin. R-scripts facilitating these 
data extraction steps are available from the authors.
 Correlation between Linkage and Association Findings 
 In order to compare results from the linkage studies with the 
recent CD GWA study  [10] , we extracted SNPs showing associa-
tion with a p value of  ! 10 –4 from their online supplementary ta-
ble 3 (www.karger.com/doi/10.1159/000228920), and mapped 
these onto the 30 cM linkage bins using the Rutgers combined 
linkage-physical map for Build 36 (http://compgen.rutgers.edu/
mapomat/). We tested for significant co-occurrence of nominally 
significant linkage findings with these association findings using 
the hypergeometric distribution. Specifically, we tested whether 
the associated SNPs were more likely to be located in bins identi-
fied in the GSMA than expected by chance, using different p val-
ue thresholds in the weighted and unweighted 30 cM GSMA.
 Results 
 Meta-analysis of eight genome-wide linkage studies in 
CD was performed both unweighted and weighted. Re-
sults based on 30 cM bin widths are summarized in  fig-
Table 1. Summary of genome-wide linkage studies included in the GSMA (ordered by year of publication)









Garner 2006 US 160 562 1.95 NPL biopsy; antibodies; DH (3%)c symptomatic; asymptomatic
Rioux 2004 Finnish 54 168d 1.04 NPL biopsy; antibodies; DH (13%)c symptomatic; asymptomatic
Van Belzen 2003 Dutch 67 142d 0.84 MLS biopsy symptomatic; asymptomatic
Popat 2002 UK, Sweden, other 24 79d 0.72 NPL ESPGAN criteria (biopsy) symptomatic
Liue 2002 Finnish 60 159 0.97 NPL biopsy; DH (22%)c symptomatic; asymptomatic 
Naluaie 2001 Scandinavian 70 156d 0.90 NPL ESPGAN criteria (biopsy) symptomatic; asymptomatic
Kinge 2000 UK 16 50 0.57 NPL biopsy; antibodies symptomatic; asymptomatic
Grecoe 1998 I 103 213d 1.02 MLS biopsy; antibodies symptomatic; asymptomatic
a MLS = Maximum likelihood statistic; NPL = non parametric 
linkage score; b Studies included patients with symptomatic CD, 
or asymptomatic CD, diagnosed through screening but without 
the presence of well-defined CD symptoms; c DH = dermatitis 
herpetiformis; percentage of DH cases among affecteds are indi-
cated; d Number of affecteds derived from information on num-
ber of affected sib pairs/trios etc or from the family trees of af-
fected families; e Study included in the previous meta/mega anal-
ysis by Babron et al. [7].
 Forabosco et al. Hum Hered 2009;68:223–230226
ure 1 and  table 2 , which lists all nominally significant 
bins (p value  ! 0.05), highlighting those with suggestive 
and genome-wide evidence for linkage.
 Genome-wide evidence for linkage was obtained in 
the HLA region (bin 6_2, i.e. the second bin on chromo-
some 6). A strong signal was also seen in the flanking bins 
(6_1 and 6_3), due to a carry-over effect from elevated 
multipoint linkage scores in an extended region of chro-
mosome 6.
 Outside the HLA region, the strongest evidence for 
linkage occurred in bin 10_6, with suggestive evidence for 
linkage in both weighted and unweighted analyses (p = 
0.00366, p = 0.00271, respectively). This telomeric region 
on chromosome 10 corresponds to the genetic interval 
144.3–173.1 cM in the Marshfield map, and to the physical 
interval 123.3–135.1 Mb in Build 36 (cytogenetic band 
10q26.12-qter). The contribution of individual studies to 
this bin suggests that most linkage evidence arises in the 
studies with broad European-ancestry studies, with weak-
er evidence from the Finnish, Scandinavian, and Dutch 
studies ( fig. 2 ). A further region on chromosome 8 showed 
suggestive evidence for linkage in the unweighted analysis 
(p = 0.00635), but only nominal significance in the weight-
ed analysis. This region (bin 8_5; 8q22.2-q24.21; 101.5–
139.5 Mb), includes rs648119 (at 103.2 Mb) which was as-
sociated with CD in the GWA study with p = 4  ! 10 –5 
 [10] . In the analysis of five studies based on classic CD pa-
tients, we observed only nominal significance in bins 10_
6 and 8_5, but suggestive significance for linkage on chro-
mosome 19 (bin 19_2, 19p13.2-q12). This bin contains 
SNP rs1036229 (at 34.7 Mb), which achieved a p value of 
2.5  ! 10 –5 in the GWA, and  MYO9B (at 17.2 Mb).
 We re-analyzed chromosomes showing suggestive ev-
idence for linkage using two narrower bin widths of 20 
cM (giving 173 bins) and 10 cM (giving 349 bins) to assess 
















































 Fig. 1. Linkage results across the genome for eight CD studies for 
the weighted analysis, showing –log10(p value) against chromo-
somal location, with a single point plotted for each 30 cM bin. 
Thresholds for nominal, suggestive, and genome-wide signifi-
cance are shown. Crossed points represent bins where SNPs with 
p  ! 10 –4 were identified in the genome-wide association study 
 [10] . p values from the hypergeometric distribution for specific 
linkage thresholds are indicated on the left. 
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age findings. Results of the weighted GSMA are shown in 
the supplementary material for chromosome 8 and 10 
(using 8 studies) and chromosome 19 (for the 5 CD-only 
studies). Similar results were obtained in the unweighted 
analysis. For chromosome 8, suggestive evidence for link-
age (p = 0.00491) was obtained with the 20 cM bin at 
99.2–118.6 Mb. No improved localization for chromo-
some 10 linkage finding was obtained. On chromosome 
19, analysis of 10 cM bins showed that the strongest evi-
dence for linkage occurred at 13.4–17.9 Mb, an interval 
which includes the  MYO9B gene.
 Testing signals of association and linkage within bins 
showed no significant evidence for co-localization of re-
sults (see  fig. 1 for bin location of association signals with 
p  ! 10 –4 and for the p values from the hypergeometric 
distribution), except for the genome-wide threshold that 
identified in the GSMA analysis the HLA region (p = 
0.02044). For example, 8 out of 117 bins showed nominal 
significance in the weighted GSMA (p  ! 0.05), and only 
3 of these were among the 33 bins containing significant 
association signals (p = 0.15123).
 Discussion 
 CD is an interesting model disorder for complex dis-
eases, as the main environmental factor (gluten) and ge-
netic factor (HLA) have been identified. Several genome-
wide linkage scans and candidate gene studies have been 
carried out to identify other genetic factors underlying 
CD, with no clear definition of further genetic contribu-
tions to CD. In this study, we performed meta-analysis of 
eight genome-wide linkage studies in CD, to summarize 
the evidence for linkage in these extensive family stud-
ies.
 Highly significant evidence for linkage was obtained 
in the HLA region and flanking regions on chromosome 
6. We also obtained suggestive evidence for linkage to the 
telomeric region of chromosome 10q. This locus provid-
ed only marginal evidence in some studies and would 
have not be identified by ad hoc assessment of individual 
scan results, showing the strength of the GSMA in iden-
tifying regions with modest but consistently elevated 
linkage scores across studies. Further, looking at the spe-
cific contributions of individual genome-wide linkage 
studies to the 10q26.12-qter region, it is apparent that 
most linkage evidence derives from studies with broad 
European ancestry, including the Italian study. An addi-
tional region on chromosome 8 showed suggestive sig-
nificance in some analyses, and includes SNP rs648119 
which was identified in the GWA  [10] , although not con-
firmed in the subsequent follow-up  [11] .
 The chromosome 5 region highlighted in the previous 
meta-analysis  [3] did not achieve even nominal signifi-
cance in this study. This inconsistency is not surprising 
given current study doubled both the number of studies 






All studies (8), p value CD studies (5), p value GWAa
unweighted weighted unweighted weighted Kb SNP
1 1_8 203–232 183–208 – 0.0416 – – 190,803 rs2816316
4 4_4 91–121 81–115 0.0411 – – –
6 6_1 0–32 0–16 <0.0001 <0.0001 0.0026 0.0012
6_2 32–64 16–42 <0.0001 <0.0001 <0.0001 <0.0001
6_3 64–97 42–89 <0.0001 <0.0001 <0.0001 <0.0001 52,573 rs6936059
8 8_5 112–140 100–129 0.0063 0.0118 0.0484 – 103,207 rs648119
9 9_3 56–84 37–85 0.0481 – – –
10 10_5 115–144 94–123 0.0360 – 0.0298 0.0369
10_6 144–173 123–135 0.0027 0.0037 0.0153 0.0227
11 11_5 118–148 123–134 0.0150 0.0229 0.0407 –
14 14_4 83–111 74–93 0.0208 0.0137 – –
19 19_2 26–53 8–36 0.0121 – 0.0037 0.0031 34,672 rs1036229
Bins with suggestive (p < 0.00847; in bold) and genome-wide (p < 0.00042; in bold and underlined) evidence for linkage are high-
lighted.
a SNPs with p < 10–4 reported in supplementary table 3 from the GWA by van Heel et al. [10].
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and the number of affected individuals included. Appli-
cation of different weighting functions did not affect re-
sults, but other explanations include the different test sta-
tistics (NPL and MLS) included in the current study (the 
previous analysis had used Kong and Cox’s Zlr statistic 
for all studies)  [25] , or a false positive finding in the initial 
meta-analysis. Analysis of the subset of four studies from 
the original meta-analysis recaptured the 5q linkage evi-
dence, implying that heterogeneity between studies, rath-
er than differences in statistical methodology may ex-
plain the discrepancy. Notably, the 5q results may be cor-
related with family structure. When we stratified the 
studies by affected sibling pairs and more extended ped-
igrees, we obtained suggestive significance in the same 5q 
region when analyzing the four affected sib pairs studies 
 [4–6, 8] . Indeed, in the previous meta-analysis, 3 of the 4 
studies included only affected sib pairs.
 In general, we observed no concordance between re-
gions showing significant linkage identified in this GSMA 
and the occurrences of the significant SNPs in genome-
wide association analysis study  [10] , except for the HLA 
locus. The number of ‘linked’ bins with significant asso-
ciation findings was not significant under either GSMA 
analysis method (weighted, unweighted) or the GSMA 
thresholds considered (suggestive significance, nominal 
significance, and p  ! 0.10). Association studies with cur-
rent SNPs platforms are aimed at identifying common 
variants involved in disease etiology, whereas linkage ap-
proaches could be used efficiently to identify multiple rare 
variants (even variation that is unique at the individual 
level) of moderate effect, which are not possible to detect 
using traditional association methods. On the other hand, 
common variants identified by van Heel et al.  [10] would 





















































































 Fig. 2. Contribution of each study at the 
identified regions on 10q26.13-qter ( a ) and 
19p13.2-q12 ( b ). The study-specific ranks 
at bin 10_6 and bin 19_2, respectively, for 
the 30 cM bin definition are shown, with 
50th and 75th percentile of the study ranks. 
White bars represent studies that included 
also DH cases. 
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 We sub-divided studies by phenotype, under the hy-
pothesis that more phenotypically homogenous studies 
may have higher power to detect linkage. Excluding three 
studies that included DH cases gave an additional region 
with suggestive evidence for linkage at 19p13.2-q12 (8–36 
Mb), which was further localised to 14.9–17.9 Mb under 
analysis with 10 cM bins. This region contains the  MYO9B 
gene located at 17.2 Mb (which was not highlighted in the 
GWA study).  MYO9B is thought to have a role in epithe-
lial barrier functions, and association with CD has been 
replicated, but does not arise in all populations  [9] . As-
sociation with inflammatory bowel disease, systemic lu-
pus erythematosus, rheumatoid arthritis, and type 1 dia-
betes have also been reported, making this gene a poten-
tial shared risk factor across autoimmune disorders.
 These results, in conjunction with data emerging from 
dense SNP typing of specific regions or future genome-
wide association studies will help guide efforts to iden-
tify the actual predisposing genetic variation contribut-
ing to this complex genetic disease. In particular, results 
from a meta-analysis of linkage studies can be used in a 
GWA study to enhance power by weighting association 
evidence using linkage results. This approach had been 
shown to have considerable powerful, if the linkage study 
is informative  [26] .
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